The antagonism of 5-HT6R improves the impaired LTP in chronic epileptic rats by regulating the KCNQ2/3-mediated M-currents, especially KCNQ2-mediated M-currents, and may serve as a promising candidate in the clinical treatment of epilepsy. The gene discussed is KCNQ2; the disease is epilepsy.